• IRS Issues Guidance on Calculation of Branded Prescription Drug Fee
  • December 10, 2010
  • Law Firm: Covington Burling LLP - Washington Office
  • On November 30, 2010, the IRS issued Notice 2010-71, which outlines the proposed method for calculating the annual fee imposed on manufacturers and importers of branded prescription drugs (“covered entities”) under the Patient Protection and Affordable Care Act (the “Affordable Care Act”).